TransMedics Group, Inc. (TMDX) on GreekSoup https://greeksoup.ai/stocks/us/tmdx/ Every dated entry in the public record on TransMedics Group, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Mon, 12 Oct 2026 00:00:00 +0000 TransMedics Group, Inc.: short interest 8,551,869 shares at the 30 September 2026 settlement, 13.07 days to coverhttps://greeksoup.ai/stocks/us/tmdx/short-interest/us:TMDX:short-interest:2026-09-30:8a743cddc2Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> TransMedics Group, Inc.: short interest 7,977,125 shares at the 15 September 2026 settlement, 10.68 days to coverhttps://greeksoup.ai/stocks/us/tmdx/short-interest/us:TMDX:short-interest:2026-09-15:5a05463f7bTue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> TransMedics Group, Inc.: Weill David (Director) bought 1,336 shares at $81.63 on 11 September 2026, $109,058https://greeksoup.ai/stocks/us/tmdx/insiders/us:TMDX:insider:2026-09-14:d4776f517cMon, 14 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> TransMedics Group, Inc. filed 8-K: officer or director change, regulation fd disclosurehttps://greeksoup.ai/stocks/us/tmdx/filings/us:TMDX:filing:2026-09-10:e106896e11Thu, 10 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> TransMedics Group, Inc.: short interest 8,079,087 shares at the 31 August 2026 settlement, 12.78 days to coverhttps://greeksoup.ai/stocks/us/tmdx/short-interest/us:TMDX:short-interest:2026-08-31:a109357af4Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> TransMedics Group, Inc.: short interest 7,910,244 shares at the 14 August 2026 settlement, 6.71 days to coverhttps://greeksoup.ai/stocks/us/tmdx/short-interest/us:TMDX:short-interest:2026-08-14:dac3355acdFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> TransMedics Group, Inc. Q2 FY2026 results: revenue $190 million, net income $15 millionhttps://greeksoup.ai/stocks/us/tmdx/results/fy2026-q2/us:TMDX:result:2026-08-04:b25166c8efTue, 04 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> TransMedics Group, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/tmdx/filings/us:TMDX:filing:2026-08-04:743ba67a90Tue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> TransMedics Group, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/tmdx/filings/us:TMDX:filing:2026-08-04:4e46551672Tue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> TransMedics Group, Inc.: short interest 7,672,830 shares at the 31 July 2026 settlement, 9.50 days to coverhttps://greeksoup.ai/stocks/us/tmdx/short-interest/us:TMDX:short-interest:2026-07-31:03f0300ea9Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> TransMedics Group, Inc.: short interest 7,715,332 shares at the 15 July 2026 settlement, 9.54 days to coverhttps://greeksoup.ai/stocks/us/tmdx/short-interest/us:TMDX:short-interest:2026-07-15:431f91b4deWed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>